Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study

PURPOSE: DA-8010 is a novel muscarinic M3 receptor antagonist with significant selectivity for bladder over salivary gland in preclinical studies. We evaluated the clinical efficacy and safety of DA-8010 in overactive bladder (OAB) patients. METHODS: This phase 2, randomized, double-blind, parallel-...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Hee Seo, Oh, Cheol Young, Choo, Myung-Soo, Kim, Hyeong Gon, Kim, Joon Chul, Lee, Kyu-Sung, Shin, Dong Gil, Cho, Sung Yong, Jeong, Seong Jin, Seo, Ju Tae, Yoon, Hana, Moon, Hong Sang, Kim, Jang Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260321/
https://www.ncbi.nlm.nih.gov/pubmed/35793990
http://dx.doi.org/10.5213/inj.2142382.191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260321/
https://www.ncbi.nlm.nih.gov/pubmed/35793990
http://dx.doi.org/10.5213/inj.2142382.191

Ejemplares similares